🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
The purpose of this study is to evaluate the safety and efficacy of aloglip...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00328627
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Status
Completed
Location
Local Institution
Start Date
2010-06
Trial ID
NCT01095666
Treatments Being Tested
This exploratory study will assess the efficacy of combined pioglitazone an...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-01-01
Trial ID
NCT06989723
This is an open-label, cross-over, fixed-sequence study. All subjects will ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02473627
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
The purpose of this study is to test the effects of study drug (GSK1605786)...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-19
Trial ID
NCT01489943
Treatments Being Tested
The purpose of this study is to determine the effects of pioglitazone, once...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00770497
Treatments Being Tested
The purpose of this study is to asses changes in glycosylated hemoglobin, f...
Status
Completed
Location
Multiple Locations
Start Date
2001-06
Trial ID
NCT00449553
The purpose of this study is to determine the Anti-Inflammation Effects of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00770445
Treatments Being Tested